Skip to main content
CLYM logo
CLYM
(NASDAQ)
Climb Bio, Inc.
$6.56-- (--)
Loading... - Market loading

Climb Bio (CLYM) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Climb Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Climb Bio, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue & Gross Profit
Revenue0.000.000.000.000.000.000.00
Cost of Revenue0.100.000.000.000.000.000.00
Gross Profit-0.100.000.000.000.000.000.00
Operating Expenses
Research & Development46.7114.3415.4126.2123.329.344.02
Selling, General & Administrative21.1716.0324.8618.9212.352.430.68
Operating Expenses67.8830.3640.2845.1435.6711.777.45
Operating Income-67.88-30.36-40.28-45.14-35.67-11.77-7.45
Other Income/Expense
Interest Income8.328.134.621.380.000.000.00
Interest Expense0.000.000.000.000.000.000.00
Other Income/Expense-0.29-51.675.16-0.11-11.810.260.90
Income
Income Before Tax-59.85-73.90-35.12-45.24-47.48-20.67-6.55
Income Tax Expense0.000.000.000.000.000.000.00
Net Income-59.85-73.90-35.12-45.24-47.48-20.67-6.55
Net Income - Continuous Operations-59.85-73.90-35.12-45.24-47.48-20.67-6.55
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-67.79-30.36-40.28-45.14-35.67-11.77-4.70
EBIT-67.88-30.36-40.28-45.14-35.67-11.770.00
Depreciation & Amortization0.100.000.000.000.000.000.00
Earnings Per Share
Basic EPS-1.00-2.00-1.00-2.00-4.00-10.00-1.00
Diluted EPS-1.00-2.00-1.00-2.00-4.00-10.00-1.00
Basic Shares Outstanding47.7748.3026.9926.3112.262.1911.66
Diluted Shares Outstanding47.7748.3026.9926.3112.262.1911.66

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.